Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Metastasis Review

• Publication date

  2012-06-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10555-012-9366-8PMID 22692478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

  2012cited by this paper
• Circulating tumor cells--new challenges ahead.

  2012cited by this paper
• Detection of Circulating Tumor Cells in Peripheral Blood of Breast Cancer Patients During or After Therapy Using a Multigene Real-Time RT-PCR Assay

  2012cited by this paper
• Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer

  2012cited by this paper
• Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.

  2012cited by this paper
• Circulating Tumor Cells as Markers for Cancer Risk Assessment and Treatment Monitoring

  2012cited by this paper
• Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

  2011cited by this paper
• Efficacy control of therapy using circulating epithelial tumor cells (CETC) as “Liquid Biopsy”: trastuzumab in HER2/neu-positive breast carcinoma

  2011cited by this paper
• Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal

  2011cited by this paper
• Circulating cancer cells and their clinical applications.

  2011cited by this paper
• SnapShot: The epithelial-mesenchymal transition.

  2011cited by this paper
• Circulating tumor cells as emerging tumor biomarkers in breast cancer

  2011cited by this paper
• Micrometastasis: Detection methods and clinical importance

  2011cited by this paper
• Angiogenesis , Metastasis , and the Cellular Microenvironment Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers

  2011cited by this paper
• Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

  2011cited by this paper
• Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437

  2011cited by this paper
• DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.

  2011cited by this paper
• Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.

  2011cited by this paper
• Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay.

  2011cited by this paper
• HER2-Positive Circulating Tumor Cells in Breast Cancer

  2011cited by this paper
• Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients

  2011cited by this paper
• The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer

  2011cited by this paper
• mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients

  2011cited by this paper
• Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.

  2011cited by this paper
• Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

  2011cited by this paper
• Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer

  2010cited by this paper
• Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

  2010cited by this paper
• Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors

  2010cited by this paper
• HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

  2010cited by this paper
• Molecular mechanisms of metastasis in breast cancer—clinical applications

  2010cited by this paper
• Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine

  2010cited by this paper
• Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

  2010cited by this paper
• Molecular Biomarker Analyses Using Circulating Tumor Cells

  2010cited by this paper
• Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells

  2010cited by this paper
• Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

  2010cited by this paper
• Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells

  2010cited by this paper
• Tumor self-seeding by circulating cancer cells.

  2009cited by this paper
• Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients

  2009cited by this paper
• Cancer micrometastases

  2009cited by this paper
• Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

  2009cited by this paper
• Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.

  2009cited by this paper
• Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence

  2009cited by this paper
• Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.

  2009cited by this paper
• HER-2, Notch, and Breast Cancer Stem Cells: Targeting an Axis of Evil

  2009cited by this paper
• Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.

  2009cited by this paper
• Quantitative determination of HER2 expression by confocal microscopy assay in CTCs of breast cancer.

  2009cited by this paper
• Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR

  2009cited by this paper
• Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

  2009cited by this paper
• Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

  2009cited by this paper
• Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients.

  2009cited by this paper
• Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

  2009cited by this paper
• Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer

  2009cited by this paper
• Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

  2009cited by this paper
• Circulating tumor cells as markers for cancer risk assessment and treatment monitoring.

  2009cited by this paper
• Detection of circulating tumor Cells in the context of treatment: Prognostic value in breast cancer patients

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

  2008cited by this paper
• Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

  2008cited by this paper
• Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

  2008cited by this paper
• Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

  2008cited by this paper
• BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.

  2008cited by this paper
• Detection of mutations in EGFR in circulating lung-cancer cells.

  2008cited by this paper
• Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.

  2007cited by this paper
• Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

  2007cited by this paper
• Isolation of rare circulating tumour cells in cancer patients by microchip technology

  2007cited by this paper
• Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.

  2007cited by this paper
• Phosphorylation of FAK, PI-3K, and Impaired Actin Organization in CK-positive Micrometastatic Breast Cancer Cells

  2007cited by this paper
• A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

  2006cited by this paper
• Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

  2006cited by this paper
• Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype

  2006cited by this paper
• A highly specific real‐time RT‐PCR method for the quantitative determination of CK‐19 mRNA positive cells in peripheral blood of patients with operable breast cancer

  2006cited by this paper
• Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.

  2006cited by this paper
• A pooled analysis of bone marrow micrometastasis in breast cancer.

  2005cited by this paper
• Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques

  2005cited by this paper
• Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.

  2005cited by this paper
• Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer

  2005cited by this paper
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

  2004cited by this paper
• HER-2 gene amplification can be acquired as breast cancer progresses.

  2004cited by this paper
• Trastuzumab Administration Can Effectively Target Chemotherapy-Resistant Cytokeratin-19 Messenger RNA–Positive Tumor Cells in the Peripheral Blood and Bone Marrow of Patients With Breast Cancer

  2004cited by this paper
• Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.

  2003cited by this paper
• Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.

  2003cited by this paper
• Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.

  2002cited by this paper
• Identification, Cloning, and Characterization of Cystatin M, a Novel Cysteine Proteinase Inhibitor, Down-regulated in Breast Cancer*

  1997cited by this paper
• Molecular Medicine

  1988cited by this paper
• Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Co-director of the North Central Cancer Treatment Group Biospecimen Resource Statement of Translational Relevance

  year unknowncited by this paper

• Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora’s Box of Multiple Myeloma

  2022cites this paper
• Circulating tumour cells in the -omics era: how far are we from achieving the ‘singularity’?

  2022cites this paper
• Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer

  2021cites this paper
• Metabolomics bridging proteomics along metabolites/oncometabolites and protein modifications: Paving the way toward integrative multiomics.

  2021cites this paper
• Biomarkers for predicting the outcome of various cancer immunotherapies.

  2020cites this paper
• Teaching Experience

  2020cites this paper
• Circulating Tumor Cells in Breast Cancer Metastatic Disease

  2020cites this paper
• Epigenetics of Circulating Tumor Cells in Breast Cancer.

  2020cites this paper
• Enrichment and ratiometric detection of circulating tumor cells using PSMA- and folate receptor-targeted magnetic and surface-enhanced Raman scattering nanoparticles.

  2020cites this paper
• Microfluidic device for circulating tumor cell quantification and capture

  2019cites this paper
• Novel approaches in cancer management with circulating tumor cell clusters

  2019cites this paper
• Summer School in Flow Cytometry for Immunology: Report From a Successful ESCCA Experience

  2019cites this paper
• CTCs Expression Profiling for Advanced Breast Cancer Monitoring

  2019cites this paper
• Single-Cell Omics: Strategies Towards Theranostic Biomarker Discovery Along the Continuum of Premalignant to Invasive Disease in Oncology

  2019cites this paper
• Precise and non-invasive circulating tumor cell isolation based on optical force using homologous erythrocyte binding.

  2019cites this paper
• Detection of circulating tumor cells based on improved SERS-active magnetic nanoparticles

  2019cites this paper
• Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases

  2019cites this paper
• Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer

  2018cites this paper
• Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer

  2018cites this paper
• Detection of Circulating Tumor Cells Using Microfluidics.

  2018cites this paper
• Review: Microfluidics technologies for blood-based cancer liquid biopsies.

  2018cites this paper
• Effective capture and release of circulating tumor cells using core-shell Fe 3 O 4 @MnO 2 nanoparticles

  2017cites this paper
• Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma

  2017cites this paper
• Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients

  2017cites this paper
• Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer

  2017cites this paper
• Circulating tumor cell as a biomarker for evaluating allogenic NK cell immunotherapy on stage IV non-small cell lung cancer.

  2017cites this paper
• Scabrous patrinia root inhibits circulating tumor cells in differentiated thyroid carcinoma - a clinical observation

  2017cites this paper
• Erratum: An optimised direct lysis method for gene expression studies on low cell numbers

  2017cites this paper
• Aptamer-functionalized nano/micro-materials for clinical diagnosis: isolation, release and bioanalysis of circulating tumor cells.

  2017cites this paper
• Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine?

  2017cites this paper
• Prediction of individual chemoprophylaxis for radiation carcinogenesis in experiment

  2017cites this paper
• Bone Marrow Micrometastases and Circulating Tumor Cells

  2016cites this paper
• Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.

  2016cites this paper
• Analysis of circulating tumor cells in colorectal cancer liver metastasis patients before and after cryosurgery

  2016cites this paper
• Signatures of breast cancer metastasis at a glance

  2016cites this paper
• Gene expression profiling and DNA methylation analyses of CTCs

  2016cites this paper
• Ensemble‐decision Aliquot Ranking (eDAR) for CTC Isolation and Analysis

  2016cites this paper
• Cancer Stem Cells and Circulating Tumor Cells: Molecular Markers, Isolation Techniques, and Clinical Implications

  2016cites this paper
• Molecular Assays for the Detection and Molecular Characterization of CTCs

  2016cites this paper
• Circulating tumour cells as biomarkers for evaluating cryosurgery on unresectable hepatocellular carcinoma.

  2016cites this paper
• Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells.

  2015influential citation
• pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma

  2015cites this paper
• AWARD NUMBER: W81XWH-13-1-0190 TITLE: THE ROLE OF SIRT1 IN BREAST CANCER STEM CELLS

  2015cites this paper
• An optimised direct lysis method for gene expression studies on low cell numbers

  2015cites this paper
• Mathematical Modeling of Cancer Metastases

  2015cites this paper
• The Role of CTCs as Tumor Biomarkers.

  2015cites this paper
• Improved method increases sensitivity for circulating hepatocellular carcinoma cells.

  2015cites this paper
• Label-free impedance detection of cancer cells from whole blood on an integrated centrifugal microfluidic platform.

  2015cites this paper
• Markers for the identification of late breast cancer recurrence

  2015cites this paper
• AWARD NUMBER: W81XWH-12-1-0076 TITLE: Development of Laser-Mediated Nanodroplet Real-Time PCR on Circulating Tumor Cells (CTC) by Microfilter Platform PRINCIPAL INVESTIGATOR:

  2015cites this paper
• Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin

  2014cites this paper
• Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.

  2014cites this paper
• Circulating Tumor Cells: A Noninvasive Liquid Biopsy in Cancer

  2014cites this paper
• PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer

  2014cites this paper
• Circulating Tumor Cells as a Real-Time Liquid Biopsy: Isolation and Detection Systems, Molecular Characterization, and Clinical Applications

  2014cites this paper
• Biology of Human Tumors PIK 3 CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer

  2014cites this paper
• The Promise of Single Cell Omics for Onco-therapy

  2014cites this paper
• Engineered decomposable multifunctional nanobioprobes for capture and release of rare cancer cells.

  2014cites this paper
• Cancer During Disease Recurrence or Progression in Patients with Breast Mutational Status in Circulating Tumor Cells

  2014cites this paper
• Circulating tumor cells as promising novel biomarkers in solid cancers

  2014cites this paper
• CellsPrimary Breast Tumors and Corresponding Circulating Tumor Breast Cancer Metastasis Suppressor-1 Promoter Methylation in

  2013cites this paper
• Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer

  2013cites this paper
• Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer

  2013cites this paper
• Enrichment, detection and clinical significance of circulating tumor cells.

  2013cites this paper
• Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells

  2013cites this paper
• A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells.

  2013cites this paper
• Personalized therapy for breast cancer: a dream or a reality?

  2013cites this paper
• Oncogenes and Tumor Suppressors Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells

  2013cites this paper
• Concomitant resistance and early-breast cancer: should we change treatment strategies?

  2013cites this paper
• Circulating tumor cells: utopia or reality?

  2013cites this paper
• Dietary selenium supplementation modifies breast tumor growth and metastasis

  2013cites this paper
• The Role of the Dysfunctional Akt-Related Pathway in Cancer: Establishment and Maintenance of a Malignant Cell Phenotype, Resistance to Therapy, and Future Strategies for Drug Development

  2013cites this paper
• Imaging multiple biomarkers in captured rare cells by sequential immunostaining and photobleaching.

  2013cites this paper
• Plasticity of disseminating cancer cells in patients with epithelial malignancies

  2012cites this paper
• Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.

  2012cites this paper